RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia
Schizophrenia affects roughly 1.1% percent of the U.S. population (3.4 million adults), with direct annual costs estimated at $47 billion. Schizophrenia is defined as a chronic, relapsing, and disabling disorder,… Read More